Abstract

Dr. Deepak Thakur*

ABSTRACT

The Coronavirus disease 2019 (COVID-19) is triggered by unadorned acute respiratory syndrome Coronavirus-2 (SARS CoV-2) infection attacking mainly on the immune system of a body. It is a possibly fatal disease that is of public health and economy disquiet globally. In December 2019, COVID-19 outburst occurred in Wuhan city, China furthermore spread worldwide. The patients with unembellished diseases may die due to acute respiratory distress syndrome (ARDS) caused by systemic inflammatory antiphons due to the excessive release of pro-inflammatory cytokines and chemokines by the immune effect or cells. In India too, it is spreading very rapidly, although the case fatality rate is below 1.50% (https:// www. statist a.com), which is markedly less than in other countries, despite the dense population and minimal health infrastructure in rura l areas. Here is an urgent need to find a specific cure for the disease and global efforts are directed at developing SARS-CoV-2 specific antivirals and immune-modulators. Ayurvedic Rasayana therapy has been traditionally used in India for its immunomodulatory and adapt genic effects, and more recently has been included as therapeutic adjuvant for several maladies. Health promotion, immune-modulation, prevention and reduce disease burden from COVID-19. Drugs such as Ashwagandha (Withania somnifera (L.) Dunal), Guduchi (Tinospora cordifolia (Willd.) Miers), Amalaki (Phyllanthus emblica L.), Mulethi (Glycyrrhiza glabra L.), Shatavari (Asparagus racemosus Willd.), Chireta (Andrographis paniculata (Burm.f.) Nees), Tulsi (Ocimum sanctum L.) Punarnava (Boerhaavia diffusa L.) and Pippali (Piper longum L.) For symptom management of COVID-19 like illness Agastya Haritaki, Anutaila, AYUSH–64 can be used. Scientific research on these drugs may reveal the new approach for the prevention and management of COVID-19. The main aim of this article is to review research which has already conducted and currently being carried out on the herbal plant for their immunomodulation property which have a possible application in the prevention and treatment of COVID-19.